BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6821469)

  • 1. Introduction to cost-benefit and cost-effectiveness analysis in health care.
    Warner KE
    Mead Johnson Symp Perinat Dev Med; 1982; (20):29-36. PubMed ID: 6821469
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of the CAT scanner and other diagnostic technologies.
    Banta HD; McNeil BJ
    Health Care Manage Rev; 1978; 3(1):7-19. PubMed ID: 10316567
    [No Abstract]   [Full Text] [Related]  

  • 3. Whitehouse lecture. Radiologic imaging: changing costs, greater benefits.
    Margulis AR
    AJR Am J Roentgenol; 1981 Apr; 136(4):657-65. PubMed ID: 6784458
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost versus cost effectiveness: the Achilles' heel for healthcare delivery.
    Wilen SB; Stone BM
    Best Pract Benchmarking Healthc; 1997; 2(3):142-4. PubMed ID: 9304910
    [No Abstract]   [Full Text] [Related]  

  • 5. Health policy uses and usefulness of cost-benefit and cost-effectiveness analysis.
    Warner KE
    Mead Johnson Symp Perinat Dev Med; 1982; (20):53-69. PubMed ID: 6821470
    [No Abstract]   [Full Text] [Related]  

  • 6. Computerized tomography: dilemma of health care technology.
    Fineberg HV
    Pediatrics; 1977 Feb; 59(2):147-9. PubMed ID: 401983
    [No Abstract]   [Full Text] [Related]  

  • 7. HEW asks full proof of efficacy, cost effectiveness of scanners.
    Foley HA
    Rev Fed Am Hosp; 1978 Mar; 11(2):21-2, 24. PubMed ID: 10306188
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evidence-based health care requires knowledge of cost-effectiveness].
    Carlsson P
    Lakartidningen; 2002 Jul; 99(30-31):3122-6. PubMed ID: 12198932
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost effectiveness in optometric health care.
    Monaco WA
    J Am Optom Assoc; 1997 Oct; 68(10):619-21. PubMed ID: 9354054
    [No Abstract]   [Full Text] [Related]  

  • 10. The costs and benefits of enhanced depression care to employers.
    Wang PS; Patrick A; Avorn J; Azocar F; Ludman E; McCulloch J; Simon G; Kessler R
    Arch Gen Psychiatry; 2006 Dec; 63(12):1345-53. PubMed ID: 17146009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of waiting time on cost-effectiveness.
    Koopmanschap MA; Brouwer WB; Hakkaart-van Roijen L; van Exel NJ
    Soc Sci Med; 2005 Jun; 60(11):2501-4. PubMed ID: 15814175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basic principles of cost-effectiveness analysis.
    Hillner BE
    Med Sect Proc; 1987; ():45-53. PubMed ID: 3133653
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of cost effectiveness analysis in health care evaluation.
    Atherly A; Culler SD; Becker ER
    Q J Nucl Med; 2000 Jun; 44(2):112-20. PubMed ID: 10967622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Economic aspects. Cost-effectiveness, cost-benefit analysis].
    Durieux P
    Rev Mal Respir; 1998 Sep; 15 Suppl 2():S37-41. PubMed ID: 9809342
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost effectiveness education--a student's viewpoint.
    Eng C
    Ohio State Med J; 1983 Dec; 79(12):899, 920. PubMed ID: 6419191
    [No Abstract]   [Full Text] [Related]  

  • 16. Health economic concepts, issues & challenges.
    Mukhopadhyay SP
    Indian J Public Health; 1994; 38(4):124-32. PubMed ID: 7797311
    [No Abstract]   [Full Text] [Related]  

  • 17. Cost-effectiveness analysis in the clinical management of patients with known or suspected lung cancer: [18F]fluorodeoxyglucose PET and CT comparison.
    Mansueto M; Grimaldi A; Torbica A; Pepe G; Giovacchini G; Messa C; Fazio F
    Q J Nucl Med Mol Imaging; 2007 Sep; 51(3):224-34. PubMed ID: 17538525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-utility of a care coordination/home telehealth programme for veterans with diabetes.
    Barnett TE; Chumbler NR; Vogel WB; Beyth RJ; Ryan P; Figueroa S
    J Telemed Telecare; 2007; 13(6):318-21. PubMed ID: 17785029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Panel discussion. I: Cost effectiveness of drug development and health economics.
    Brody BA; Feinstein AR; Furberg CD; Siegenthaler W; Urquhart I; Weihrauch TR
    Arzneimittelforschung; 1989 Aug; 39(8A):989-95. PubMed ID: 2510747
    [No Abstract]   [Full Text] [Related]  

  • 20. [Economics and organization of health care. II. Suitability and effectiveness].
    Stolte JB; Heesters JP; Leers M
    Ned Tijdschr Geneeskd; 1984 Feb; 128(6):268-71. PubMed ID: 6424037
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.